# Situation: A 45-year-old man is on day 5 after a living-donor kidney transplant. He takes tacrolimus at 8:00 AM and 8:00 PM, mycophenolate, and prednisone. He has an indwelling urinary catheter, and his urine output over the past day was 150–200 mL/h. Four months later, at a clinic visit, his serum creatinine has risen from 1.2 mg/dL (106 µmol/L) to 1.9 mg/dL (168 µmol/L) over 1 week. His urine output has decreased, his temperature is 37.9 °C, and the graft site is tender. His tacrolimus trough level is within the target range, and he has no tremor. How should the nurse classify this problem?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=629829  
> language: ko  
> subject: Nursing Practice III — Care of Clients with Problems in Surgery, Oxygenation, Fluid and Electrolytes, Infectious, Inflammatory and Immunologic Response, Cellular Aberrations

## 문제

Situation: A 45-year-old man is on day 5 after a living-donor kidney transplant. He takes tacrolimus at 8:00 AM and 8:00 PM, mycophenolate, and prednisone. He has an indwelling urinary catheter, and his urine output over the past day was 150–200 mL/h.

Four months later, at a clinic visit, his serum creatinine has risen from 1.2 mg/dL (106 µmol/L) to 1.9 mg/dL (168 µmol/L) over 1 week. His urine output has decreased, his temperature is 37.9 °C, and the graft site is tender. His tacrolimus trough level is within the target range, and he has no tremor. How should the nurse classify this problem?

## 보기

1. Acute rejection, which is often reversible **✔ 정답**
2. Hyperacute rejection from preformed antibodies
3. Tacrolimus toxicity damaging the kidney graft
4. Chronic rejection from slow scarring of vessels

**정답: 1**

## 해설

Acute rejection occurs over days to months, most often in the first 6 months, and shows a rising creatinine, falling urine output, fever, and graft tenderness; it is usually reversible with prompt treatment. Hyperacute rejection occurs within minutes to hours of transplant, and chronic rejection causes slow loss of function over months to years without fever or tenderness. A trough level within range and no tremor make calcineurin inhibitor toxicity unlikely.

## 심화 해설

Clinical classification of graft dysfunction

The presentation points to acute rejection. The timing—4 months after transplantation—falls within the highest-risk window for acute rejection, which is most common during the first 6 months after kidney transplantation [1]. The clinical picture is classic: a rise in serum creatinine from 1.2 mg/dL to 1.9 mg/dL over 1 week, decreased urine output, low-grade fever (37.9 °C), and graft tenderness. Acute rejection typically presents as unexplained graft dysfunction with fever and graft site pain, and it is often reversible when recognized and treated promptly.

The differential diagnosis can be narrowed by the tacrolimus trough level. Because the trough is within the target range and there is no tremor, calcineurin inhibitor toxicity is unlikely as the primary cause of the creatinine rise. Toxicity from tacrolimus is generally associated with supratherapeutic trough levels and neurologic findings such as tremor, which are absent here.

Watch out! Hyperacute rejection occurs within minutes to hours after reperfusion, not at 4 months. Chronic rejection develops over months to years as a slow, progressive decline in graft function, typically without fever or graft tenderness. The acute onset of fever and tenderness in this patient makes chronic rejection less consistent with the findings.

| Feature | Acute rejection | Hyperacute rejection | Chronic rejection | Tacrolimus toxicity |
| --- | --- | --- | --- | --- |
| Typical onset | Days to months, peak in first 6 months | Minutes to hours after transplant | Months to years, slow progression | Any time, related to drug level |
| Creatinine trend | Rising over days to weeks | Immediate graft failure | Slowly rising over months | Rising, often dose-dependent |
| Fever and graft tenderness | Common | Graft is lost rapidly | Usually absent | Usually absent |
| Trough level | Often within range | Not relevant | Often within range | Elevated |
| Reversibility | Often reversible with prompt treatment | Generally irreversible | Generally progressive, less responsive | Reversible with dose reduction |

Key point! Acute rejection should remain high on the differential diagnosis for any unexplained graft dysfunction, because early recognition and treatment can preserve long-term graft survival. Tissue biopsy remains the gold standard for confirming the type and severity of rejection, including distinguishing T-cell–mediated from antibody-mediated processes [1]. Antibody-mediated rejection is increasingly recognized as a major cause of graft loss and can occur even when trough levels are therapeutic, particularly in the setting of nonadherence or HLA sensitization . In this patient, the clinical pattern of fever, graft tenderness, rising creatinine, and decreased urine output at 4 months post-transplant is most consistent with acute rejection, which is often reversible with prompt immunosuppressive escalation [1].References (research sources)

- [1]Evaluation and Treatment of Acute Rejection in Kidney Allografts.Research articleCooper JE (2020) · DOI: 10.2215/CJN.11991019

## 임상 시나리오

Acute Rejection After Kidney TransplantRecognizing reversible graft dysfunction
Acute rejection is most common in the first 6 months after transplant and presents with rising creatinine, decreased urine output, fever, and graft tenderness.

A tacrolimus trough level within target range and absence of tremor make calcineurin inhibitor toxicity unlikely.

CautionHyperacute rejection occurs within minutes to hours after reperfusion, not months later. Chronic rejection lacks fever and tenderness.

## 핵심 개념

- **Acute rejection** — Graft dysfunction occurring days to months post-transplant, often with fever, graft tenderness, and rising creatinine; usually reversible with prompt treatment.
- **Hyperacute rejection** — Immediate rejection within minutes to hours after reperfusion caused by preformed antibodies.
- **Chronic rejection** — Slow, progressive loss of graft function over months to years without fever or tenderness.
- **Tacrolimus trough level** — Blood concentration measured before the next dose; supratherapeutic levels suggest calcineurin inhibitor toxicity.
- **Graft tenderness** — Pain or discomfort over the transplanted organ, a clinical sign of acute rejection.

## 같은 주제 문제

- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629716)
- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629717)
- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629718)
- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629719)
- [Situation: A 34-year-old man was diagnosed with human immunodeficiency virus (HIV) infecti…](https://mymerci.kr/pages/nclex_q.php?qn_id=629720)
- [Situation: A 34-year-old man was diagnosed with human immunodeficiency virus (HIV) infecti…](https://mymerci.kr/pages/nclex_q.php?qn_id=629721)
- [Situation: A 34-year-old man was diagnosed with human immunodeficiency virus (HIV) infecti…](https://mymerci.kr/pages/nclex_q.php?qn_id=629722)
- [Situation: A 41-year-old man is admitted to the medical ward with weakness that began in b…](https://mymerci.kr/pages/nclex_q.php?qn_id=629723)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._